How AI will help us to better define patient populations? What for?
Joseph GLIGOROV
oncologist, Paris, France
oncologist, Paris, France
Management of hard-to-treat thoracic malignancies with ablation.
Shahabazali PATIL
Radiologist, Abou Dhabi, EAU
What is the status of pathologists in the context of a multidisciplinary tumor boards?
Fréderique PENAULT LORCA
Chairwoman of the Pathology department, University Hospital, Clermont Ferrand, France
Where do we stand in developing radionuclides against molecular markers overexpressed on breast cancer (BC) cells such as EGFR-family members?
Willy Vangu
nuclear medicine, Johannesburg, South Africa